Trivitron Healthcare has announced the launch of a mobile laboratory to facilitate Covid-19 diagnosis in rural, urban and remote locations. The lab is expected to be deployed in rural and inaccessible areas of India and is capable of processing approximately 2,500 samples every day, including RT-PCR tests, rapid antigen tests, CLIA/Elisa antibodies tests IgG and IgM and CLIA/Elisa tests for inflammatory markers like D-Dimer, CRP and IL-6.

Promega has received a CE mark for its Covid-19 antibody test, the Lumit Dx SARS-CoV-2 Immunoassay, which will now be available in Europe. The new bioluminescent immunoassay is a qualitative in vitro diagnostic test, which detects antibodies against the SARS-CoV-2 virus in serum. It is being regarded as a simple, scalable, and reliable method for detection.

Safeguard DNA Diagnostics, a Philippines-based molecular microbiology diagnostic laboratory, has launched the Rhinostics dry nasal and nasopharyngeal collection swabs for Covid-19 testing. The swabs are being introduced at its facilities in Davao, Metro Manila and Negros Occidental. The company will also be the exclusive supplier of Rhinostics in the Philippines. The swabs have received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA), and allow for easy sample collection, dry shipment, as well as transport without viral transport media.